GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Srx Health Solutions SRXH · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.87

+7.20%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Srx Health Solutions

From its filings with the US Securities and Exchange Commission

SEC filings

Srx Health Solutions is based in North Palm Beach, Florida and is incorporated in Delaware. Its shares trade on NYSE under the ticker SRXH. The SEC classifies its business as beverages. In the fiscal year to 30 September 2025, it reported revenue of $6.5m and a net loss of $45.0m. At that date it held total assets of $8.4m and shareholders' equity of $407,000.

In its own words

Better Choice Company, Inc. (“Better Choice” or “BTTR”), the pet health and wellness business.

SRx’s former business. These legacy operations are reported as discontinued operations in the financial statements.

SRx provided specialty pharmaceutical products and related services to healthcare providers and patients across various therapeutic areas.

Over time, the Company pursued acquisitions and expansion strategies aimed at growing its product portfolio and market presence.

Blue Buffalo (part of General Mills), Wellness, Fromm, Orijen, Merrick (part of Nestlé), Stella and Chewy, Open Farm and Freshpet.

Quoted from its 10-K, filed 5 Dec 2025. Read the filing on SEC.gov ↗

Company facts

Sector
Consumer Staples
Industry
Personal Products
Listed since
16 Jun 2010
Employees
10
Head office
801 US HIGHWAY 1, NORTH PALM BEACH, FL, 33408
Incorporated in
DE
Classification
Beverages
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Lionel ConacherIndependent Chairman of the Board, since 2021$172,481
  • Mr. Kent CunninghamPresident, Chief Executive Officer, since 2023$681,262
  • Mrs. Carolina MartinezChief Financial Officer$463,495
  • Mr. Joshua EpsteinDirector
  • Mr. Simon ConwayIndependent Director
  • Mr. David WhiteIndependent Director
  • Mr. Michael YoungIndependent Director$172,481
  • Mr. Valter PintoManaging Director, since 2020

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company operates in the growing animal health sector.
  • It utilizes a dual distribution model with retail and direct channels.
  • Products are available under multiple recognized brand names.

Weaknesses

  • The firm reports only ten employees in the provided data.
  • Another source claims zero full-time employees exist.
  • This discrepancy suggests potential operational or reporting issues.

Opportunities

  • The direct-to-consumer online platform allows for direct engagement.
  • The pet specialty and grocery retail channels offer expansion potential.
  • Growing demand for natural pet supplements supports sales.

Threats

  • Competition is intense within the consumer products industry.
  • Reliance on e-commerce retailers creates channel dependency.
  • Regulatory changes may impact hemp-based product sales.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.